Global β-Lactam Antibiotics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global β-Lactam Antibiotics Market Research Report 2024
β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure. These antibiotics have the advantages of strong bactericidal activity, low toxicity, wide indications and good clinical efficacy.
According to Mr Accuracy reports new survey, global β-Lactam Antibiotics market is projected to reach US$ 37790 million in 2029, increasing from US$ 27220 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole β-Lactam Antibiotics market research.
Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categoriesß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global β-Lactam Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Segment by Type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The β-Lactam Antibiotics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global β-Lactam Antibiotics market is projected to reach US$ 37790 million in 2029, increasing from US$ 27220 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole β-Lactam Antibiotics market research.
Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categoriesß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global β-Lactam Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Segment by Type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The β-Lactam Antibiotics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices